Skip to main content
Equibles
BTAIQ logo

BTAIQ · BioXcel Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track BTAIQ — free

Use BTAIQ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTAIQ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.05 +0.01 (+13.30%) At close · Oct 6
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$1.19M
Shares
31.31M
Volume · Oct 6 278K Avg daily vol (3M) 6.07M

BioXcel Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for BioXcel Therapeutics, Inc. (BTAIQ), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $137,000 −$41.80M '22 Q3 22-11-10 · $206,000 −$52.80M '23 Q1 23-05-08 · $457,000 −$53.52M '23 Q2 23-08-14 ▲148.9% $341,000 −$50.49M '23 Q3 23-11-14 · $376,000 −$22.26M '23 Q4 24-03-12 ▲182.5% $582,000 −$26.79M '24 Q1 24-05-09 ▲141.6% $1.10M −$8.30M '24 Q2 24-08-06 ▼37.2% $214,000 −$13.65M '24 Q3 24-11-14 ▼89.1% $120,000 −$19.19M '25 Q2 25-08-14 LATEST ▼54.2% $98,000 −$30.91M '25 Q3 25-12-08
Earnings call
FY25 · Q3
2025-12-08
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2025 Earnings Call
Revenue
$98,000
▼ 54.2% YoY
Diluted EPS
$-2.18
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-08-27
BioXcel Therapeutics, Inc. (BTAIQ) August 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q2
2025-08-14
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2025 Earnings Call
Revenue
$120,000
▼ 89.1% YoY
Diluted EPS
$-2.45
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-11-14
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2024 Earnings Call Transcript
Balanced tone SERENITY at-home Phase 3 trial Intellectual property portfolio IGALMI commercial performance
Revenue
$214,000
▼ 37.2% YoY
Diluted EPS
$-5.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2024 Earnings Call
Revenue
$1.10M
▲ 141.6% YoY
Diluted EPS
$-3.30
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
BioXcel Therapeutics, Inc. (BTAIQ) Q1 2024 Earnings Call Transcript
Positive tone Alzheimer's agitation opportunity IGALMI commercialization BXCL701 immuno-oncology asset
Revenue
$582,000
▲ 182.5% YoY
Diluted EPS
$-13.89
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
BioXcel Therapeutics, Inc. (BTAIQ) Q4 2023 Earnings Call Transcript
Balanced tone TRANQUILITY program in Alzheimer's agitation SERENITY at-home program in bipolar/schizophrenia IGALMI commercial launch and J-code
Revenue
$376,000*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-14
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2023 Earnings Call Transcript
Revenue
$341,000
▲ 148.9% YoY
Diluted EPS
$-27.52
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2023 Earnings Call Transcript
Revenue
$457,000
Diluted EPS
$-29.28
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
BioXcel Therapeutics, Inc. (BTAIQ) Q1 2023 Earnings Call Transcript
Revenue
$206,000
Diluted EPS
$-29.44
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
BioXcel Therapeutics, Inc. (BTAIQ) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2022 Earnings Call Transcript
Revenue
$137,000
Diluted EPS
$-23.84
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2022 Earnings Call Transcript
Diluted EPS
$-21.60
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
BioXcel Therapeutics, Inc. (BTAIQ) Q1 2022 Earnings Call Transcript
Diluted EPS
$-17.92
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-13
BioXcel Therapeutics, Inc. (BTAIQ) Q4 2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2021 Earnings Call
Diluted EPS
$-15.36
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2021 Earnings Call
Diluted EPS
$-17.76
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-10
BioXcel Therapeutics, Inc. (BTAIQ) Q1 2021 Earnings Call
Diluted EPS
$-17.28
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
BioXcel Therapeutics, Inc. (BTAIQ) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
BioXcel Therapeutics, Inc. (BTAIQ) Q3 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-14
BioXcel Therapeutics, Inc. (BTAIQ) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
BioXcel Therapeutics, Inc. (BTAIQ) Q1 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-09
BioXcel Therapeutics, Inc. (BTAIQ) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–23 of 23 webcasts
Key facts CIK 1720893 Visit website Investor relations